Aspirin reduced recurrence by 50% in PIK3CA-mutated colorectal cancer, the DCISionRT test earned FDA breakthrough status for ...
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
9d
In a bombshell announcement made last week, the Food and Drug Administration (FDA) said it will ban the use of FD&C Red No. 3 ...
Interesting Engineering on MSN2d
Sniffing out cancer: Scientists test nasal drug for deadly pancreatic tumorsA groundbreaking approach led by a team of scientists, including Rice University chemist James Tour, has the potential to ...
Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...
The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...
On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...
HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...
Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.
The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer with disease progression after endocrine therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback